Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 30, 2026

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents
09:45

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents

Published on: November 12, 2016

32.0K

[TERT]

Koichi Ichimura

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |January 13, 2019
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
    08:36

    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

    Published on: April 7, 2023

    1.6K
    Preparation of 6-aminocyclohepta-2,4-dien-1-one Derivatives via Tricarbonyltroponeiron
    07:56

    Preparation of 6-aminocyclohepta-2,4-dien-1-one Derivatives via Tricarbonyltroponeiron

    Published on: August 12, 2019

    8.3K

    Related Experiment Videos

    Last Updated: Jan 30, 2026

    A Protocol for Safe Lithiation Reactions Using Organolithium Reagents
    09:45

    A Protocol for Safe Lithiation Reactions Using Organolithium Reagents

    Published on: November 12, 2016

    32.0K
    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
    08:36

    Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

    Published on: April 7, 2023

    1.6K
    Preparation of 6-aminocyclohepta-2,4-dien-1-one Derivatives via Tricarbonyltroponeiron
    07:56

    Preparation of 6-aminocyclohepta-2,4-dien-1-one Derivatives via Tricarbonyltroponeiron

    Published on: August 12, 2019

    8.3K

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

    EClinicalMedicine·2026
    Same author

    VGLL-fused intraparenchymal schwannoma with EWSR1::VGLL1 fusion: integrated clinicopathological and molecular characterization.

    Acta neuropathologica communications·2026
    Same author

    TANC1::HTRA1 and KPNA4::WWTR1 fusions in non-vestibular intracranial schwannomas.

    Acta neuropathologica·2026
    Same author

    Efficacy and safety of multimodality therapy stratified by resection rate and molecular markers in children and adolescents with ependymoma: JCCG EPN23 protocol.

    Japanese journal of clinical oncology·2026
    Same author

    Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

    The Lancet. Child & adolescent health·2026
    Same author

    MUC4-Positive Fibroblastoma: Clinicopathological and Molecular Analysis of 7 Cases.

    The American journal of surgical pathology·2026
    Same journal

    [Development of novel therapeutics for multiple myeloma and improvement of drug lag].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Clinical pharmacy services to patients of immunomodulatory drugs].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    See all related articles